glp 1 weight loss drugs list GLP-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness list of glp-1 drugs for

For health and nutrition professionals, it's a timely reminder to stay grounded in evidence not headlines

Indianapolis, Indiana: Eli Lilly & Co

Heres how the top providers stack up on the four questions we get the most

Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future

About the Author Pamela Maragliano, DMD Pamela Maragliano, DMD, is the chief editor of Dental Economics

[DOI] [PubMed] [Google Scholar] 156.Gariani K, de Seigneux S, Moll S